Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease

• DOI: 10.1016/j.jchf.2023.03.024
• Publication Date: 2023-05-17T18:00:24Z
• Authors: Aliza Hussain; David Ramsey; Michelle Lee; Dhruv Mahtta; Muhammad Shahzeb ...; Vijay Nambi; Christie M. Balla...; Laura A. Petersen; Adrienne D. Walker; Waleed T. Kayani; Javed Butler; Leandro Slipczuk; Joseph G. Rogers; Biykem Bozkurt; Sankar D. Navanee...; Salim S. Virani
• Keywords: Atherosclerotic cardiovascular disease